Japan is advancing research to apply induced pluripotent stem cell (iPSC) to treat heart diseases. After the world’s first-of-its-kind iPSC-based heart cell transplant in January, a second clinical trial has been approved this summer and the third is in the pipeline. Currently, cardiac insufficiency can only be cured by transplants but the waiting list for a donor is long. There are hopes that the new treatment will provide new alternatives in the future.
Life Science & Medical Technology
Masks made of nonwoven fabric performed best in a Japanese supercomputer model of their ability to block virus-carrying respiratory droplets, but other types of masks also showed effectiveness.
Japan's Fujifilm Holdings said Monday that it has won an order to produce a key component of American biotechnology company Novavax's coronavirus vaccine candidate at a site in the U.K.